Smith & Nephew expands wound care offering with Healthpoint buy

11/29/2012 | Bloomberg

Smith & Nephew has agreed to pay $782 million to acquire Healthpoint Biotherapeutics, maker of the Santyl ointment used to debride wounds of dead tissue. The deal is expected to allow Smith & Nephew to gain a foothold in the bioactive wound care market and strengthen its advanced wound management business, CEO Olivier Bohuon said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY